Home LiteratureArticle Details
PMID: 3257577 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Learning from lesions: patterns of tissue inflammation in leprosy.

Modlin RL, Melancon-Kaplan J, Young SM, Pirmez C, Kino H, Convit J, Rea TH, Bloom BR

Abstract

The clinical forms of leprosy constitute a spectrum that correlates closely with the degree of cell-mediated immunity. Patients with tuberculoid leprosy develop strong cell-mediated responses and have only a few, localized lesions, whereas patients with multibacillary lepromatous leprosy are specifically unresponsive to antigens of Myobacterium leprae. T cells of the CD4+ subset predominate in tuberculoid lesions, whereas CD8+ cells predominate in lepromatous lesions. Monoclonal antibodies that distinguish subpopulations of CD4+ and CD8+ cells were used to analyze the distribution of T cells infiltrating lesions across the disease spectrum. In lepromatous lesions, T cells of T-suppressor phenotype (9.3-) were the predominant CD8+ cells and suppressor/inducer cells (2H4+, Leu-8+) represented half of the CD4+ subset. In tuberculoid lesions, helper T cells (CD4+4B4+) outnumbered suppressor/inducer T cells by 14:1, compared with a ratio of 1.2:1 in peripheral blood. Analysis of the precursor frequency of antigen-reactive T cells permitted us to estimate that there was a 100-fold enrichment of T cells able to proliferate in response to M. leprae antigens in tuberculoid lesions (2/100), when compared with blood from the same patients. The methods used here to characterize the T-lymphocyte subsets and frequency of antigen-reactive T cells in leprosy may be useful in analyzing immunological reactions occurring in lesions of other inflammatory and autoimmune diseases.

MeSH Terms
Antibodies, Monoclonal/immunology Antigens, Differentiation, T-Lymphocyte/analysis Cells, Cultured Granuloma/pathology Humans Immunity, Cellular Inflammation Interleukin-2/pharmacology Leprosy/immunology,pathology Lymphocyte Activation Phenotype T-Lymphocytes/classification,drug effects,immunology
Chemicals
Antibodies, Monoclonal Antigens, Differentiation, T-Lymphocyte Interleukin-2
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Modlin R L
Section of Dermatology, University of Southern California School of Medicine, Los Angeles 90033.
Melancon-Kaplan J
Young S M
Pirmez C
Kino H
Convit J
Rea T H
Bloom B R
References (17)
17 references, click to expand
  1. Classification of leprosy according to immunity. A five-group system.
    Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255-73 PMID: 5950347
  2. Immunoregulatory T lymphocytes in man. Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+CD45R-p80+ subpopulation.
    J Immunol. 1987 Sep 1;139(5):1501-8 PMID: 2887618
  3. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.
    J Immunol. 1981 Apr;126(4):1614-9 PMID: 7009746
  4. The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes.
    N Engl J Med. 1982 Dec 23;307(26):1593-7 PMID: 6216407
  5. T lymphocyte subsets in the skin lesions of patients with leprosy.
    J Am Acad Dermatol. 1983 Feb;8(2):182-9 PMID: 6219136
  6. Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts.
    Int J Lepr Other Mycobact Dis. 1982 Dec;50(4):415-24 PMID: 6763002
  7. In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor.
    J Immunol. 1984 Jun;132(6):3085-90 PMID: 6327818
  8. The isolation and characterization of the human suppressor inducer T cell subset.
    J Immunol. 1985 Mar;134(3):1508-15 PMID: 3155770
  9. The isolation and characterization of the human helper inducer T cell subset.
    J Immunol. 1985 Jun;134(6):3762-9 PMID: 3157750
  10. Monoclonal antibody 9.3 and anti-CD11 antibodies define reciprocal subsets of lymphocytes.
    Eur J Immunol. 1985 Dec;15(12):1164-8 PMID: 3936719
  11. Homing receptors and the control of lymphocyte migration.
    Immunol Rev. 1986 Jun;91:39-60 PMID: 2426181
  12. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
    Nature. 1986 Jul 31-Aug 6;322(6078):459-61 PMID: 2942780
  13. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
    Nature. 1986 Jul 31-Aug 6;322(6078):462-4 PMID: 2426597
  14. Suppressor T lymphocytes from lepromatous leprosy skin lesions.
    J Immunol. 1986 Nov 1;137(9):2831-4 PMID: 2944966
  15. Phenotypic identification of suppressor-effector, suppressor-amplifier and suppressor-inducer T cells of B cell differentiation in man.
    Eur J Immunol. 1987 Apr;17(4):453-7 PMID: 2952513
  16. An HLA-linked gene controls susceptibility to lepromatous leprosy through T cell regulation.
    Lepr Rev. 1986 Dec;57 Suppl 2:139-42 PMID: 2952854
  17. Quantification of antigen-reactive cells among human T lymphocytes.
    Eur J Immunol. 1978 Jul;8(7):477-84 PMID: 80324
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1988-02-00
Pages
1213-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC279737
Subset
IM
Grants
NIAID NIH HHS · AI07118 · United States
NIAID NIH HHS · AI22187 · United States
NIAID NIH HHS · AI22553 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]